Sars-Cov-2 And Covid-19 Research
811 researchers across 15 institutions
Research in SARS-CoV-2 and COVID-19 investigates the complex biological, medical, and societal dimensions of the virus and the disease it causes. Studies examine viral mechanisms, including its genetic evolution, replication strategies, and interactions with host cells. This work also encompasses the development and evaluation of diagnostic tools, therapeutic interventions, and vaccines. Beyond the biological aspects, researchers explore the clinical manifestations of COVID-19, patient outcomes, long-term health effects, and the epidemiology of the pandemic. Methodologies range from laboratory-based molecular and cellular biology to clinical trials, epidemiological modeling, and health services research.
The impact of SARS-CoV-2 and COVID-19 is particularly relevant to Arkansas. Research addresses health disparities and outcomes within the state's diverse populations, seeking to understand and mitigate unequal disease burdens. Investigations also inform public health strategies and policies tailored to the specific demographic and geographic characteristics of Arkansas communities. The economic implications for sectors such as healthcare, agriculture, and tourism are also examined, alongside the behavioral and psychological impacts on individuals and communities across the state.
This area of study draws on expertise from a wide array of disciplines. It is closely connected to public health research, behavioral and psychological studies, child and adolescent health, microbial infections and disease research, health sciences research and education, healthcare policy and management, and meta-analysis and systematic reviews. Engagement spans multiple higher education institutions and research centers throughout Arkansas, fostering a collaborative approach to understanding and addressing the challenges posed by the pandemic.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Michael B. Smith | UAMS | 73 | 16,758 | Grant PI High Impact | |
| Robert J. Griffin | UAMS | 71 | 25,813 | Grant PI High Impact | |
| Roger Brown | UAMS | 65 | 15,703 | High Impact | |
| David W. Ussery | UAMS | 62 | 26,087 | ARA High Impact | |
| Byron L. Zamboanga | University of Arkansas | 58 | 13,331 | Grant PI High Impact | |
| Paula K. Roberson | UAMS | 58 | 15,638 | High Impact | |
| Mario Schootman | University of Arkansas | 56 | 13,684 | Grant PI High Impact | |
| Xin Li | UAMS | 55 | 9,842 | High Impact | |
| Horace J. Spencer | UAMS | 54 | 10,299 | High Impact | |
| Paul C. Howard | NCTR | 49 | 7,511 | High Impact | |
| R. W. Gibson | University of Arkansas | 47 | 6,422 | High Impact Grants | |
| Harry Anthony Patrinos | University of Arkansas | 47 | 11,603 | High Impact | |
| Chris Barker | Harding University Main Campus | 47 | 9,259 | Emeritus | High Impact |
| Peter M. Mourani | UAMS | 46 | 9,375 | High Impact | |
| Mohsen Bazargan | University of Arkansas | 46 | 7,464 | High Impact | |
| C. L. Chien | UAMS | 46 | 11,576 | ||
| Ángel Serrano‐Aroca | Southern Arkansas University | 45 | 7,603 | High Impact | |
| Volodymyr Tryndyak | NCTR | 44 | 6,602 | High Impact | |
| Brian Storrie | UAMS | 44 | 6,570 | Grant PI High Impact | |
| Nickolas Zaller | University of Arkansas | 43 | 5,810 | High Impact |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Sars-Cov-2 And Covid-19 Research in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 2,778
- 2 Johns Hopkins University 2,190
- 3 National Institutes of Health 2,086
- 4 University of Washington 1,850
- 5 University of North Carolina at Chapel Hill 1,694
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Sars-Cov-2 And Covid-19 Research.